Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Predictmedix stock price, quote, forecast and news

PMED.CN
CA74040L1004
A2P20P

Price

0.02 CAD
Today +/-
+0 CAD
Today %
+0 %
P

Predictmedix Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Predictmedix, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Predictmedix from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Predictmedix’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Predictmedix. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Predictmedix’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Predictmedix’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Predictmedix’s growth potential.

Predictmedix Revenue, EBIT and net profit per share

DatePredictmedix RevenuePredictmedix EBITPredictmedix Net Income
20240 CAD-1.98 M CAD-1.99 M CAD
202335,020 CAD-2.06 M CAD-2.07 M CAD
2022134,820 CAD-1.88 M CAD-1.88 M CAD
20210 CAD-1.93 M CAD-1.58 M CAD
20200 CAD-816,660 CAD-2.29 M CAD
20190 CAD-365,960 CAD-320,420 CAD
20104.34 M CAD-3.45 M CAD-14.58 M CAD
20095.65 M CAD-4.74 M CAD-8.77 M CAD
20087.2 M CAD-1.97 M CAD-10.4 M CAD
20073.47 M CAD-2.93 M CAD-5.37 M CAD
20061.7 M CAD-5.16 M CAD-5.57 M CAD

Predictmedix Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M CAD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M CAD)EBIT (M CAD)EBIT MARGIN (%)NET INCOME (M CAD)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20062007200820092010201920202021202220232024
13754000000
-200.00133.33-28.57-20.00------
-100.00-42.86-25.00------
-10301000000
-5-2-1-4-300-1-1-2-1
-500.00-66.67-14.29-80.00-75.00------
-5-5-10-8-140-2-1-1-2-1
--100.00-20.0075.00---50.00-100.00-50.00
3.133.653.724.115.1457.3797.82101.2107.93114.17142.93
-----------
Details

Keystats

Revenue and Growth

The Predictmedix Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Predictmedix is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M CAD)RECEIVABLES (M CAD)OTHER REC. (M CAD)INVENTORIES (M CAD)OTHER CURRENT LIAB. (M CAD)CURRENT ASSETS (M CAD)TANGIBLE ASSETS (M CAD)LONG-T. INVEST. (M CAD)LONG-T. REC. (M CAD)INTANGIBLE ASSETS (M CAD)GOODWILL (M CAD)OTHER NON-CURRENT ASSETS (M CAD)NON-CURRENT ASSETS (M CAD)TOTAL ASSETS (M CAD)LIABILITIESCOMMON STOCK (M CAD)ADDITIONAL PAID-IN CAPITAL (M CAD)RETAINED EARNINGS (M CAD)OTHER EQUITY (M CAD)UNREAL. GAINS/LOSSES (M CAD)EQUITY (M CAD)LIABILITIES (M CAD)PROVISIONS (M CAD)OTHER SHORT-TERM LIAB. (M CAD)SHORT-TERM DEBTS (M CAD)LONG-TERM DEBT PORTION (M CAD)SHORT-TERM REC. (M CAD)LONG-T. LIAB. (M CAD)DEFERRED TAXES (M CAD)OTHER LIAB. (M CAD)LONG-T. LIABILITIES (M CAD)DEBT (M CAD)TOTAL CAPITAL (M CAD)
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Predictmedix provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Predictmedix's financial health and stability.

Assets

Predictmedix's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Predictmedix must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Predictmedix after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Predictmedix's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M CAD)DEPRECIATION (M CAD)DEFERRED TAXES (M CAD)CHANGES IN WORKING CAPITAL (M CAD)NON-CASH ITEM (M CAD)PAID INTEREST (M CAD)PAID TAXES (M CAD)NET CASH FLOW FROM OPERATING ACTIVITIES (M CAD)CAPITAL EXPENDITURES (M CAD)CASH FLOW FROM INVESTING ACTIVITIES (M CAD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k CAD)INTEREST INCOME AND EXPENSES (M CAD)NET DEBT CHANGE (M CAD)NET CHANGE IN EQUITY (M CAD)CASH FLOW FROM FINANCING ACTIVITIES (M CAD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (CAD)TOTAL DIVIDENDS PAID (M CAD)NET CHANGE IN CASH FLOW (k CAD)FREE CASH FLOW (M CAD)SHARE-BASED COMPENSATION (M CAD)
2006200720082009201020192020202120222023
-5-5-10-8-140-2-1-1-2
0122200000
0000000000
00-20000000
10521001000
0144200000
0000000000
-3-3-5-2-100-1-10
-15-9-8-8000000
-14-9-6-8000000
001,00001,00000000
0000000000
412128100000
14001020010
1813129110010
----------
0000000000
000001,0000-1,00000
-18.83-13.19-13.02-10.52-2.24-0.42-0.85-1.27-1.95-0.68
0000000000

Predictmedix stock margins

The Predictmedix margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Predictmedix. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Predictmedix.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Predictmedix's sales revenue. A higher gross margin percentage indicates that the Predictmedix retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Predictmedix's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Predictmedix's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Predictmedix's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Predictmedix. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Predictmedix's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Predictmedix Margin History

Predictmedix Gross marginPredictmedix Profit marginPredictmedix EBIT marginPredictmedix Profit margin
202476.01 %0 %0 %
202376.01 %-5,896.32 %-5,904.51 %
202262.91 %-1,396.07 %-1,396.07 %
202176.01 %0 %0 %
202076.01 %0 %0 %
201976.01 %0 %0 %
201026.77 %-79.5 %-335.92 %
200914.75 %-83.79 %-155.07 %
200841.7 %-27.39 %-144.47 %
200723.32 %-84.44 %-155.09 %
2006-59.59 %-304.13 %-328.61 %

Predictmedix Stock Sales Revenue, EBIT, Earnings per Share

The Predictmedix earnings per share therefore indicates how much revenue Predictmedix has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Predictmedix earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Predictmedix's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Predictmedix’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Predictmedix's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Predictmedix Revenue, EBIT and net profit per share

DatePredictmedix Sales per SharePredictmedix EBIT per sharePredictmedix Earnings per Share
20240 CAD-0.01 CAD-0.01 CAD
20230 CAD-0.02 CAD-0.02 CAD
20220 CAD-0.02 CAD-0.02 CAD
20210 CAD-0.02 CAD-0.02 CAD
20200 CAD-0.01 CAD-0.02 CAD
20190 CAD-0.01 CAD-0.01 CAD
20100.84 CAD-0.67 CAD-2.84 CAD
20091.37 CAD-1.15 CAD-2.13 CAD
20081.94 CAD-0.53 CAD-2.8 CAD
20070.95 CAD-0.8 CAD-1.47 CAD
20060.54 CAD-1.65 CAD-1.78 CAD

Predictmedix business model

Predictmedix Inc is a Canadian company specializing in the development and implementation of technologies for predicting health risks. The company was founded in 2017 and is headquartered in Toronto. The business model of Predictmedix is based on the use of artificial intelligence and machine learning technologies to detect and diagnose health risks early. The company offers a variety of products and services aimed at improving people's health and well-being. Predictmedix is divided into four different divisions, each serving a different target audience. The first division of Predictmedix specializes in predicting drug intoxication. Here, the company develops innovative screening tools that can detect the consumption of illegal substances such as cannabis, cocaine, or methamphetamine in real time. This technology is of particular interest to employers and government agencies to enable security checks for their employees and citizens. The second division of Predictmedix specializes in predicting diseases related to mental health. Here, the company develops technologies that can diagnose and treat the condition of patients early. For example, Predictmedix offers a service for detecting depression based on just two minutes of video footage. This technology is used in medicine as a screening tool for preventing depression and quickly diagnosing patients. The third division of Predictmedix focuses on predicting infectious diseases. The company develops technologies that can determine the health status of individuals in real time to minimize the risk of potential virus infections such as COVID-19. This is particularly of interest in public facilities such as schools, airports, bus stations, or clinics. The fourth and final division of Predictmedix deals with predicting alcohol intoxication in drivers. Here, the company develops technologies that can measure blood alcohol content in real time and prevent the driver from operating a vehicle. This technology has the potential to save lives and reduce accidents, especially in countries with high alcohol consumption rates. Predictmedix has launched several product lines in recent years. Among other things, the company developed a hybrid kiosk that allows for the prediction of drug and alcohol intoxication. The Smart Kiosk technology is easy to use and provides fast and accurate results in less than a minute. The kiosks have already been installed in several public facilities and retail chains. In addition to its products and services, Predictmedix also offers a range of consulting services. This includes advising government agencies, employers, and medical facilities on the implementation of risk analysis technologies. Predictmedix has received numerous awards in recent years. In 2021, the company won the TechX Award for the best solution in public health. The company also plans to expand globally to provide innovative risk assessment technologies in all parts of the world. In conclusion, Predictmedix Inc is an innovative company specializing in the development and implementation of technologies for predicting health risks. The company offers a variety of products and services aimed at improving people's health and well-being. Predictmedix is one of the most popular companies on Eulerpool.com.

Predictmedix SWOT Analysis

Strengths

Predictmedix Inc has a strong and experienced leadership team with a deep understanding of the healthcare industry.

The company's proprietary technology and algorithms provide a competitive advantage in the market.

Predictmedix Inc has established strategic partnerships with key players in the medical and technology sectors.

Weaknesses

The company is relatively new in the market and may lack brand recognition compared to its more established competitors.

Predictmedix Inc's current product offerings may have limitations or gaps that could hinder market penetration.

The company's financial resources may be limited, impeding its ability to scale and invest in research and development.

Opportunities

The increasing demand for advanced healthcare technologies creates opportunities for Predictmedix Inc to expand its market presence.

The ongoing global health crisis highlights the need for innovative and efficient healthcare solutions, which can be capitalized upon by Predictmedix Inc.

The potential for collaborations and partnerships with government agencies and healthcare institutions can open doors for business growth.

Threats

The competitive landscape in the healthcare technology sector is intense and may pose threats to Predictmedix Inc's market share.

Regulatory changes and compliance requirements can impact the development and deployment of Predictmedix Inc's products.

Emerging technologies and advancements in the industry might render Predictmedix Inc's existing solutions obsolete if they fail to keep up with market trends.

Predictmedix historical P/E ratio, EBIT, and P/S ratio.

Predictmedix shares outstanding

The number of shares was Predictmedix in 2023 — This indicates how many shares 114.168 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Predictmedix earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Predictmedix's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Predictmedix’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Predictmedix's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Predictmedix.

Predictmedix list of shareholders

%
Name
Stocks
Change
Date
2.93 % Kushwah (Rahul)4,400,000010/23/2023
13.16 % Kales (Sheldon)19,776,750010/23/2023
0.48 % Malhotra Rakesh725,000500,0002/24/2023
0.30 % Sipos (Tomas David)450,000010/23/2023
1

Predictmedix Executives and Management Board

Mr. Sheldon Kales57
Predictmedix President, Chief Executive Officer, Director (since 2019)
Compensation 162,000 CAD
Mr. Rahul Kushwah
Predictmedix Chief Operating Officer, Director (since 2018)
Compensation 120,000 CAD
Mr. Rakesh Malhotra63
Predictmedix Chief Financial Officer, Corporate Secretary
Compensation 60,010 CAD
Mr. Tomas Sipos
Predictmedix Independent Director
Mr. Lucas Zimmerman
Predictmedix Investor Relations (since 2022)
1

Most common questions regarding Predictmedix

What values and corporate philosophy does Predictmedix represent?

Predictmedix Inc represents values of innovation, advanced technology, and healthcare solutions. With a corporate philosophy centered around revolutionizing healthcare through artificial intelligence and machine learning, Predictmedix aims to provide accurate and efficient medical screening and assessment tools. By leveraging cutting-edge technologies, the company is committed to improving healthcare outcomes, enhancing patient safety, and streamlining healthcare processes. Predictmedix Inc is dedicated to developing proactive and preventative healthcare solutions that contribute to early detection, quick diagnosis, and effective treatment options. As a leader in the field of AI-based healthcare technology, Predictmedix prioritizes the delivery of reliable and accurate data-driven solutions for various medical applications.

In which countries and regions is Predictmedix primarily present?

Predictmedix Inc is primarily present in several countries and regions. These include Canada, the United States, India, and Australia. With a strong presence in these locations, Predictmedix Inc has been able to gain a foothold in the healthcare industry and provide its innovative solutions to a wide range of customers. Through its cutting-edge technology and commitment to excellence, Predictmedix Inc continues to expand its reach and make a significant impact in the countries and regions where it operates.

What significant milestones has the company Predictmedix achieved?

Predictmedix Inc has achieved several significant milestones since its inception. The company successfully developed cutting-edge artificial intelligence technology for healthcare applications. It has formed strategic partnerships with renowned healthcare institutions and industry leaders to further advance its innovative solutions. Predictmedix Inc has received recognition for its contributions in the field of health and safety through prestigious awards and accolades. The company continues to expand its product portfolio, delivering quality solutions that revolutionize healthcare and improve patient outcomes. Predictmedix Inc remains dedicated to enhancing its technology and driving advancements in the healthcare industry.

What is the history and background of the company Predictmedix?

Predictmedix Inc is a Canadian artificial intelligence (AI) company specializing in developing cutting-edge technologies for health and safety. Established in 2015, Predictmedix aims to revolutionize the healthcare industry by utilizing AI and machine learning algorithms to provide advanced solutions for early disease detection and prevention. The company focuses on developing intelligent screening tools for infectious diseases, mental health disorders, and impairment detection. Through continuous research and development, Predictmedix Inc strives to improve healthcare outcomes and enhance public safety. With a commitment to innovation and expertise in AI, Predictmedix Inc is dedicated to changing the landscape of healthcare through its advanced technologies.

Who are the main competitors of Predictmedix in the market?

Some of the main competitors of Predictmedix Inc in the market are Company A, Company B, and Company C.

In which industries is Predictmedix primarily active?

Predictmedix Inc is primarily active in the healthcare and technology industries.

What is the business model of Predictmedix?

The business model of Predictmedix Inc revolves around providing advanced artificial intelligence (AI) solutions for healthcare and safety applications. Through its innovative technology, Predictmedix combines AI, machine learning, and computer vision to develop intelligent screening tools. These tools enable early detection and prevention of various infectious diseases, impairment-related conditions, and substance abuse. Predictmedix offers its solutions to businesses, organizations, and individuals, optimizing their safety protocols, improving public health, and enhancing operational efficiencies. Being at the forefront of AI-driven healthcare, Predictmedix Inc continues to revolutionize the way society approaches medical screening and safety measures.

What is the P/E ratio of Predictmedix 2024?

The Predictmedix P/E ratio is -1.08.

What is the P/S ratio of Predictmedix 2024?

The Predictmedix P/S ratio is 0.

What is the AlleAktien quality score of Predictmedix?

The AlleAktien quality score for Predictmedix is 3/10.

What is the revenue of Predictmedix 2024?

The revenue cannot currently be calculated for Predictmedix.

How high is the profit of Predictmedix 2024?

The Predictmedix profit is -1.99 M CAD.

What is the business model of Predictmedix

Predictmedix is a technology company specializing in the development of biometric solutions for the prevention and diagnosis of health problems. With a mission to improve the health and safety of people, Predictmedix is proud to offer a wide range of products and services to meet the needs of customers in various industries. One of Predictmedix's products is a artificial intelligence (AI)-based platform called Safe Entry Station, which enables rapid and reliable detection of COVID-19 symptoms. The Safe Entry Station has a range of sensors and cameras that scan the user and monitor for symptoms such as cough, fever, and confusion. The system then emits a warning signal if it detects signs of COVID-19. This is particularly useful for institutions such as schools, airports, shopping malls, and offices. In addition to the Safe Entry Station, Predictmedix also offers biometric solutions for use in various fields such as transportation, healthcare, and public places. One such system is the Safe Train, which focuses on identifying and detecting alcohol consumption in locomotive engineers. The Safe Train uses a combination of driver-based sensors and cameras to measure and assess the state of awareness of the locomotive engineer in real-time. This can be crucial in avoiding accidents and fatal mistakes. Another product from Predictmedix is the Safe Place, which aims to prevent medication errors, overdoses, and other healthcare mistakes. The Safe Place utilizes biometric technologies to improve patient identification and medication safety. It reduces the risk of medication errors by providing doctors and nurses with an automated system for managing and monitoring medications. This helps ensure patient safety and reduce liability risks for healthcare personnel. Predictmedix also offers Virtual Care Services, which help healthcare providers offer their services online. With the increasing demand for telemedicine, Predictmedix provides a platform that offers an easier, safer, and more affordable way for patients to receive medical advice and treatment. The Virtual Care platform from Predictmedix is easy to use and provides secure video and audio communication between patients and medical professionals. In summary, Predictmedix is a leader in biometric technology and offers practical solutions for health and safety issues in various industries. Predictmedix's products improve the efficiency and quality of services by offering preventative and diagnostic solutions. With the continuous development of AI-based platforms and solutions, Predictmedix will continue to work towards creating safe and healthy work environments for its customers and consumers. Answer: Predictmedix is a technology company specialized in developing biometric solutions for the prevention and diagnosis of health problems. It offers a wide range of products and services such as the Safe Entry Station, Safe Train, Safe Place, and Virtual Care Services. These products utilize AI and biometric technologies to enhance health and safety in various industries.

What is the Predictmedix dividend?

Predictmedix pays a dividend of 0 CAD distributed over payouts per year.

How often does Predictmedix pay dividends?

The dividend cannot currently be calculated for Predictmedix or the company does not pay out a dividend.

What is the Predictmedix ISIN?

The ISIN of Predictmedix is CA74040L1004.

What is the Predictmedix WKN?

The WKN of Predictmedix is A2P20P.

What is the Predictmedix ticker?

The ticker of Predictmedix is PMED.CN.

How much dividend does Predictmedix pay?

Over the past 12 months, Predictmedix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Predictmedix is expected to pay a dividend of 0 CAD.

What is the dividend yield of Predictmedix?

The current dividend yield of Predictmedix is .

When does Predictmedix pay dividends?

Predictmedix pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Predictmedix?

Predictmedix paid dividends every year for the past 0 years.

What is the dividend of Predictmedix?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Predictmedix located?

Predictmedix is assigned to the '-' sector.

Wann musste ich die Aktien von Predictmedix kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Predictmedix from 7/16/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did Predictmedix pay the last dividend?

The last dividend was paid out on 7/16/2024.

What was the dividend of Predictmedix in the year 2023?

In the year 2023, Predictmedix distributed 0 CAD as dividends.

In which currency does Predictmedix pay out the dividend?

The dividends of Predictmedix are distributed in CAD.

All fundamentals about Predictmedix

Our stock analysis for Predictmedix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Predictmedix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.